Immune mechanisms in fibrotic interstitial lung disease-Reference-Cited by-同舟云学术

Immune mechanisms in fibrotic interstitial lung disease

Published:2024-07 Issue:14 Volume:187 Page:3506-3530
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Kamiya Mari,Carter Hannah,Espindola Milena S.,Doyle Tracy J.,Lee Joyce S.,Merriam Louis T.,Zhang Fan,Kawano-Dourado Leticia,Sparks Jeffrey A.,Hogaboam Cory M.,Moore Bethany B.,Oldham William M.,Kim Edy Y.^ORCID

Funder

American Lung Association

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Gordon and Llura Gund Foundation

Pharmaceutical Research and Manufacturers of America Foundation

Arthritis National Research Foundation

Foundation for the National Institutes of Health

National Heart Lung and Blood Institute

Publisher

Elsevier BV

Reference218 articles.

1. Global trends of interstitial lung diseases from 1990 to 2019: an age–period–cohort study based on the Global Burden of Disease study 2019, and projections until 2030;Zeng;Front. Med.,2023

2. Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis;Zheng;ERJ Open Res.,2022

3. Idiopathic pulmonary fibrosis;Martinez;Nat. Rev. Dis. Primers,2017

4. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline;Raghu;Am. J. Respir. Crit. Care Med.,2022

5. Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis;Taillé;Am. J. Respir. Crit. Care Med.,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review;Autoimmunity Reviews;2024-10